Latest Market News

Bio-Gene Technology Limited has received a $519,500 R&D tax incentive from the Australian government, supporting its development of innovative bio-insecticides targeting insecticide resistance.

Pacific Edge reports a $19.1 million net loss for the first half of FY26 amid Medicare coverage loss but positions itself for a Medicare-led recovery with strong clinical evidence and a key advisory committee meeting set for February 2026.

Forrestania Resources Limited has initiated an all-scrip off-market takeover offer for Kula Gold Limited, aiming to consolidate gold exploration assets across Western Australia. The offer, valued up to $58.7 million, comes with unanimous backing from Kula's board.

Finbar Group has completed settlement on a prime South Perth development site valued at approximately $187 million, advancing its substantial $1.2 billion project pipeline with a market launch planned for 2026.

A former director of Emu NL has lodged a formal application with the Takeovers Panel, contesting the legitimacy of a recent $1.4 million institutional placement and alleging undisclosed attempts to influence board control.

Forrestania Resources has updated the opening date of its Share Purchase Plan to 9 December 2025, aligning it with key corporate events and offering shareholders a chance to buy shares at $0.175 each alongside new option incentives.

Sea Forest Limited launches a $20.5 million IPO on the ASX to scale production and commercialisation of SeaFeed™, a scientifically validated livestock feed additive that cuts methane emissions by up to 80% while boosting productivity.

Venus Metals Corporation has acknowledged an on-market takeover bid from QGold at $0.17 per share, matching the last closing price. The Venus Board advises shareholders to take no immediate action as they assess the offer’s value against the company’s substantial asset base.

Euroz Hartleys Group Limited reported a robust FY2025 with an 87.7% jump in net profit and a strong start to FY2026, driven by increased brokerage and capital markets activity.

Sequoia Financial Group has acknowledged that ASIC’s civil penalty proceedings against its subsidiary InterPrac are material and confirmed timely disclosure to the market following formal notification.

Race Oncology Limited has secured shareholder approval for a replacement Constitution at its 2025 Annual General Meeting, updating its corporate governance framework to align with current regulatory standards.

Wesfarmers Limited announces a fully franked special dividend of AUD 0.40 per share alongside a $1.10 capital return, both payable on December 4, 2025. Eligible shareholders can participate in the Dividend Investment Plan for the dividend component, marking a significant move in the company’s 2025 capital management strategy.